APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nitinol Medical Components

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nitinol Medical Components Market Outlook and Growth Opportunities 2026

Report ID 173916590427 December 2025202 pages

Choose your research edition.

Industry ResearchNitinol Medical Components Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Nitinol Medical Components Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Nitinol Medical Components Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nitinol Medical Components Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Nitinol Medical Components Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Nitinol Medical Components market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nitinol Medical Components is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nitinol Medical Components is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nitinol Medical Components is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nitinol Medical Components market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nitinol Medical Components market include Acandis, AMETEK Engineered Medical Components, Artivion, BD, Biotronik, Cook Medical, Cordis, DePuy Synthes (Johnson＆Johnson) and Edwards Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nitinol Medical Components market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nitinol Medical Components and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nitinol Medical Components sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nitinol Medical Components market size, projected growth trends, production technologies, key applications, and end-use industries.

Nitinol Medical Components Segment by Company

Acandis

AMETEK Engineered Medical Components

Artivion

BD

Biotronik

Cook Medical

Cordis

DePuy Synthes (Johnson＆Johnson)

Edwards Lifesciences

ELLA-CS

Olympus

Stryker

Terumo Interventional Systems

B. Braun

Boston Scientific

Medtronic

Abbott

Nitinol Medical Components Segment by Type

Implants(Stents、Screws, etc.)

Surgical Instruments(Guidewires, etc.)

Others

Nitinol Medical Components Segment by Application

Dental

Cardiovascular Field

Orthopedic

Others

Nitinol Medical Components Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nitinol Medical Components status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nitinol Medical Components market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nitinol Medical Components significant trends, drivers, influence factors in global and regions.

6. To analyze Nitinol Medical Components competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitinol Medical Components market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nitinol Medical Components and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitinol Medical Components.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nitinol Medical Components market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nitinol Medical Components industry.

Chapter 3: Detailed analysis of Nitinol Medical Components manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nitinol Medical Components in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nitinol Medical Components in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nitinol Medical Components Industry Trends Table 2. Nitinol Medical Components Industry Drivers Table 3. Nitinol Medical Components Industry Opportunities and Challenges Table 4. Nitinol Medical Components Industry Restraints Table 5. Global Nitinol Medical Components Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nitinol Medical Components Revenue Share by Company (2021-2026) Table 7. Global Nitinol Medical Components Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Nitinol Medical Components Sales Volume Share by Company (2021-2026) Table 9. Global Nitinol Medical Components Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Nitinol Medical Components Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nitinol Medical Components Key Company Manufacturing Base & Headquarters Table 12. Global Nitinol Medical Components Company, Product Type & Application Table 13. Global Nitinol Medical Components Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nitinol Medical Components by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Implants(Stents、Screws, etc.) Table 18. Significant Companies of Surgical Instruments(Guidewires, etc.) Table 19. Significant Companies of Others Table 20. Global Nitinol Medical Components Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Nitinol Medical Components Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Nitinol Medical Components Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Nitinol Medical Components Sales Volume Share by Type (2021-2026) Table 24. Global Nitinol Medical Components Sales Volume Share by Type (2027-2032) Table 25. Global Nitinol Medical Components Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nitinol Medical Components Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Nitinol Medical Components Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Nitinol Medical Components Sales Value Share by Type (2021-2026) Table 29. Global Nitinol Medical Components Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Dental Table 31. Significant Companies of Cardiovascular Field Table 32. Significant Companies of Orthopedic Table 33. Significant Companies of Others Table 34. Global Nitinol Medical Components Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Nitinol Medical Components Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Nitinol Medical Components Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Nitinol Medical Components Sales Volume Share by Application (2021-2026) Table 38. Global Nitinol Medical Components Sales Volume Share by Application (2027-2032) Table 39. Global Nitinol Medical Components Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Nitinol Medical Components Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Nitinol Medical Components Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Nitinol Medical Components Sales Value Share by Application (2021-2026) Table 43. Global Nitinol Medical Components Sales Value Share by Application (2027-2032) Table 44. Global Nitinol Medical Components Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Nitinol Medical Components Sales by Region (2021-2026) & (K Units) Table 46. Global Nitinol Medical Components Sales Market Share by Region (2021-2026) Table 47. Global Nitinol Medical Components Sales by Region (2027-2032) & (K Units) Table 48. Global Nitinol Medical Components Sales Market Share by Region (2027-2032) Table 49. Global Nitinol Medical Components Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Nitinol Medical Components Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Nitinol Medical Components Sales Value Share by Region (2021-2026) Table 52. Global Nitinol Medical Components Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Nitinol Medical Components Sales Value Share by Region (2027-2032) Table 54. Global Nitinol Medical Components Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Nitinol Medical Components Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Nitinol Medical Components Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Nitinol Medical Components Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Nitinol Medical Components Sales by Country (2021-2026) & (K Units) Table 59. Global Nitinol Medical Components Sales Market Share by Country (2021-2026) Table 60. Global Nitinol Medical Components Sales by Country (2027-2032) & (K Units) Table 61. Global Nitinol Medical Components Sales Market Share by Country (2027-2032) Table 62. Global Nitinol Medical Components Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Nitinol Medical Components Sales Value Market Share by Country (2021-2026) Table 64. Global Nitinol Medical Components Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Nitinol Medical Components Sales Value Market Share by Country (2027-2032) Table 66. Acandis Company Information Table 67. Acandis Business Overview Table 68. Acandis Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Acandis Nitinol Medical Components Product Portfolio Table 70. Acandis Recent Development Table 71. AMETEK Engineered Medical Components Company Information Table 72. AMETEK Engineered Medical Components Business Overview Table 73. AMETEK Engineered Medical Components Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AMETEK Engineered Medical Components Nitinol Medical Components Product Portfolio Table 75. AMETEK Engineered Medical Components Recent Development Table 76. Artivion Company Information Table 77. Artivion Business Overview Table 78. Artivion Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Artivion Nitinol Medical Components Product Portfolio Table 80. Artivion Recent Development Table 81. BD Company Information Table 82. BD Business Overview Table 83. BD Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. BD Nitinol Medical Components Product Portfolio Table 85. BD Recent Development Table 86. Biotronik Company Information Table 87. Biotronik Business Overview Table 88. Biotronik Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Biotronik Nitinol Medical Components Product Portfolio Table 90. Biotronik Recent Development Table 91. Cook Medical Company Information Table 92. Cook Medical Business Overview Table 93. Cook Medical Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Cook Medical Nitinol Medical Components Product Portfolio Table 95. Cook Medical Recent Development Table 96. Cordis Company Information Table 97. Cordis Business Overview Table 98. Cordis Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Cordis Nitinol Medical Components Product Portfolio Table 100. Cordis Recent Development Table 101. DePuy Synthes (Johnson＆Johnson) Company Information Table 102. DePuy Synthes (Johnson＆Johnson) Business Overview Table 103. DePuy Synthes (Johnson＆Johnson) Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. DePuy Synthes (Johnson＆Johnson) Nitinol Medical Components Product Portfolio Table 105. DePuy Synthes (Johnson＆Johnson) Recent Development Table 106. Edwards Lifesciences Company Information Table 107. Edwards Lifesciences Business Overview Table 108. Edwards Lifesciences Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Edwards Lifesciences Nitinol Medical Components Product Portfolio Table 110. Edwards Lifesciences Recent Development Table 111. ELLA-CS Company Information Table 112. ELLA-CS Business Overview Table 113. ELLA-CS Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. ELLA-CS Nitinol Medical Components Product Portfolio Table 115. ELLA-CS Recent Development Table 116. Olympus Company Information Table 117. Olympus Business Overview Table 118. Olympus Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Olympus Nitinol Medical Components Product Portfolio Table 120. Olympus Recent Development Table 121. Stryker Company Information Table 122. Stryker Business Overview Table 123. Stryker Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Stryker Nitinol Medical Components Product Portfolio Table 125. Stryker Recent Development Table 126. Terumo Interventional Systems Company Information Table 127. Terumo Interventional Systems Business Overview Table 128. Terumo Interventional Systems Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Terumo Interventional Systems Nitinol Medical Components Product Portfolio Table 130. Terumo Interventional Systems Recent Development Table 131. B. Braun Company Information Table 132. B. Braun Business Overview Table 133. B. Braun Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. B. Braun Nitinol Medical Components Product Portfolio Table 135. B. Braun Recent Development Table 136. Boston Scientific Company Information Table 137. Boston Scientific Business Overview Table 138. Boston Scientific Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Boston Scientific Nitinol Medical Components Product Portfolio Table 140. Boston Scientific Recent Development Table 141. Medtronic Company Information Table 142. Medtronic Business Overview Table 143. Medtronic Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Medtronic Nitinol Medical Components Product Portfolio Table 145. Medtronic Recent Development Table 146. Abbott Company Information Table 147. Abbott Business Overview Table 148. Abbott Nitinol Medical Components Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Abbott Nitinol Medical Components Product Portfolio Table 150. Abbott Recent Development Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Nitinol Medical Components Distributors List Table 154. Nitinol Medical Components Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Nitinol Medical Components Product Image Figure 2. Global Nitinol Medical Components Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nitinol Medical Components Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nitinol Medical Components Sales (2021-2032) & (K Units) Figure 5. Global Nitinol Medical Components Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Nitinol Medical Components Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Implants(Stents、Screws, etc.) Image Figure 10. Surgical Instruments(Guidewires, etc.) Image Figure 11. Others Image Figure 12. Global Nitinol Medical Components Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Nitinol Medical Components Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Nitinol Medical Components Sales Volume Share by Type (2021-2032) Figure 15. Global Nitinol Medical Components Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Nitinol Medical Components Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Nitinol Medical Components Sales Value Share by Type (2021-2032) Figure 18. Dental Image Figure 19. Cardiovascular Field Image Figure 20. Orthopedic Image Figure 21. Others Image Figure 22. Global Nitinol Medical Components Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Nitinol Medical Components Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Nitinol Medical Components Sales Volume Share by Application (2021-2032) Figure 25. Global Nitinol Medical Components Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Nitinol Medical Components Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Nitinol Medical Components Sales Value Share by Application (2021-2032) Figure 28. Global Nitinol Medical Components Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Nitinol Medical Components Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Nitinol Medical Components Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Nitinol Medical Components Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Nitinol Medical Components Sales Value (2021-2032) & (US$ Million) Figure 33. North America Nitinol Medical Components Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Nitinol Medical Components Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Nitinol Medical Components Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Nitinol Medical Components Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Nitinol Medical Components Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Nitinol Medical Components Sales Value (2021-2032) & (US$ Million) Figure 39. South America Nitinol Medical Components Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Nitinol Medical Components Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Nitinol Medical Components Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Nitinol Medical Components Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Nitinol Medical Components Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Nitinol Medical Components Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Implants(Stents、Screws, etc.)
  • Surgical Instruments(Guidewires, etc.)
  • Others
Applications
  • Dental
  • Cardiovascular Field
  • Orthopedic
  • Others
Companies covered
  • Acandis
  • AMETEK Engineered Medical Components
  • Artivion
  • BD
  • Biotronik
  • Cook Medical
  • Cordis
  • DePuy Synthes (Johnson＆Johnson)
  • Edwards Lifesciences
  • ELLA-CS
  • Olympus
  • Stryker
  • Terumo Interventional Systems
  • B. Braun
  • Boston Scientific
  • Medtronic
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nitinol Medical Components Sales Value (2021-2032)
  4. 1.2.2 Global Nitinol Medical Components Sales Volume (2021-2032)
  5. 1.2.3 Global Nitinol Medical Components Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nitinol Medical Components Market Dynamics
  1. 2.1 Nitinol Medical Components Industry Trends
  2. 2.2 Nitinol Medical Components Industry Drivers
  3. 2.3 Nitinol Medical Components Industry Opportunities and Challenges
  4. 2.4 Nitinol Medical Components Industry Restraints
3 Nitinol Medical Components Market by Company
  1. 3.1 Global Nitinol Medical Components Company Revenue Ranking in 2025
  2. 3.2 Global Nitinol Medical Components Revenue by Company (2021-2026)
  3. 3.3 Global Nitinol Medical Components Sales Volume by Company (2021-2026)
  4. 3.4 Global Nitinol Medical Components Average Price by Company (2021-2026)
  5. 3.5 Global Nitinol Medical Components Company Ranking (2024-2026)
  6. 3.6 Global Nitinol Medical Components Company Manufacturing Base and Headquarters
  7. 3.7 Global Nitinol Medical Components Company Product Type and Application
  8. 3.8 Global Nitinol Medical Components Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nitinol Medical Components Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nitinol Medical Components Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nitinol Medical Components Market by Type
  1. 4.1 Nitinol Medical Components Type Introduction
  2. 4.1.1 Implants(Stents、Screws, etc.)
  3. 4.1.2 Surgical Instruments(Guidewires, etc.)
  4. 4.1.3 Others
  5. 4.2 Global Nitinol Medical Components Sales Volume by Type
  6. 4.2.1 Global Nitinol Medical Components Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nitinol Medical Components Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Nitinol Medical Components Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Nitinol Medical Components Sales Value by Type
  10. 4.3.1 Global Nitinol Medical Components Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Nitinol Medical Components Sales Value by Type (2021-2032)
  12. 4.3.3 Global Nitinol Medical Components Sales Value Share by Type (2021-2032)
5 Nitinol Medical Components Market by Application
  1. 5.1 Nitinol Medical Components Application Introduction
  2. 5.1.1 Dental
  3. 5.1.2 Cardiovascular Field
  4. 5.1.3 Orthopedic
  5. 5.1.4 Others
  6. 5.2 Global Nitinol Medical Components Sales Volume by Application
  7. 5.2.1 Global Nitinol Medical Components Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Nitinol Medical Components Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Nitinol Medical Components Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Nitinol Medical Components Sales Value by Application
  11. 5.3.1 Global Nitinol Medical Components Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Nitinol Medical Components Sales Value by Application (2021-2032)
  13. 5.3.3 Global Nitinol Medical Components Sales Value Share by Application (2021-2032)
6 Nitinol Medical Components Regional Sales and Value Analysis
  1. 6.1 Global Nitinol Medical Components Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nitinol Medical Components Sales by Region (2021-2032)
  3. 6.2.1 Global Nitinol Medical Components Sales by Region: 2021-2026
  4. 6.2.2 Global Nitinol Medical Components Sales by Region (2027-2032)
  5. 6.3 Global Nitinol Medical Components Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nitinol Medical Components Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nitinol Medical Components Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nitinol Medical Components Sales Value by Region (2027-2032)
  9. 6.5 Global Nitinol Medical Components Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nitinol Medical Components Sales Value (2021-2032)
  12. 6.6.2 North America Nitinol Medical Components Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nitinol Medical Components Sales Value (2021-2032)
  15. 6.7.2 Europe Nitinol Medical Components Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nitinol Medical Components Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nitinol Medical Components Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nitinol Medical Components Sales Value (2021-2032)
  21. 6.9.2 South America Nitinol Medical Components Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nitinol Medical Components Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nitinol Medical Components Sales Value Share by Country, 2025 VS 2032
7 Nitinol Medical Components Country-level Sales and Value Analysis
  1. 7.1 Global Nitinol Medical Components Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nitinol Medical Components Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nitinol Medical Components Sales by Country (2021-2032)
  4. 7.3.1 Global Nitinol Medical Components Sales by Country (2021-2026)
  5. 7.3.2 Global Nitinol Medical Components Sales by Country (2027-2032)
  6. 7.4 Global Nitinol Medical Components Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nitinol Medical Components Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nitinol Medical Components Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nitinol Medical Components Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nitinol Medical Components Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nitinol Medical Components Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Acandis
  2. 8.1.1 Acandis Company Information
  3. 8.1.2 Acandis Business Overview
  4. 8.1.3 Acandis Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Acandis Nitinol Medical Components Product Portfolio
  6. 8.1.5 Acandis Recent Developments
  7. 8.2 AMETEK Engineered Medical Components
  8. 8.2.1 AMETEK Engineered Medical Components Company Information
  9. 8.2.2 AMETEK Engineered Medical Components Business Overview
  10. 8.2.3 AMETEK Engineered Medical Components Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 AMETEK Engineered Medical Components Nitinol Medical Components Product Portfolio
  12. 8.2.5 AMETEK Engineered Medical Components Recent Developments
  13. 8.3 Artivion
  14. 8.3.1 Artivion Company Information
  15. 8.3.2 Artivion Business Overview
  16. 8.3.3 Artivion Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Artivion Nitinol Medical Components Product Portfolio
  18. 8.3.5 Artivion Recent Developments
  19. 8.4 BD
  20. 8.4.1 BD Company Information
  21. 8.4.2 BD Business Overview
  22. 8.4.3 BD Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BD Nitinol Medical Components Product Portfolio
  24. 8.4.5 BD Recent Developments
  25. 8.5 Biotronik
  26. 8.5.1 Biotronik Company Information
  27. 8.5.2 Biotronik Business Overview
  28. 8.5.3 Biotronik Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Biotronik Nitinol Medical Components Product Portfolio
  30. 8.5.5 Biotronik Recent Developments
  31. 8.6 Cook Medical
  32. 8.6.1 Cook Medical Company Information
  33. 8.6.2 Cook Medical Business Overview
  34. 8.6.3 Cook Medical Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cook Medical Nitinol Medical Components Product Portfolio
  36. 8.6.5 Cook Medical Recent Developments
  37. 8.7 Cordis
  38. 8.7.1 Cordis Company Information
  39. 8.7.2 Cordis Business Overview
  40. 8.7.3 Cordis Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Cordis Nitinol Medical Components Product Portfolio
  42. 8.7.5 Cordis Recent Developments
  43. 8.8 DePuy Synthes (Johnson＆Johnson)
  44. 8.8.1 DePuy Synthes (Johnson＆Johnson) Company Information
  45. 8.8.2 DePuy Synthes (Johnson＆Johnson) Business Overview
  46. 8.8.3 DePuy Synthes (Johnson＆Johnson) Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 DePuy Synthes (Johnson＆Johnson) Nitinol Medical Components Product Portfolio
  48. 8.8.5 DePuy Synthes (Johnson＆Johnson) Recent Developments
  49. 8.9 Edwards Lifesciences
  50. 8.9.1 Edwards Lifesciences Company Information
  51. 8.9.2 Edwards Lifesciences Business Overview
  52. 8.9.3 Edwards Lifesciences Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Edwards Lifesciences Nitinol Medical Components Product Portfolio
  54. 8.9.5 Edwards Lifesciences Recent Developments
  55. 8.10 ELLA-CS
  56. 8.10.1 ELLA-CS Company Information
  57. 8.10.2 ELLA-CS Business Overview
  58. 8.10.3 ELLA-CS Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ELLA-CS Nitinol Medical Components Product Portfolio
  60. 8.10.5 ELLA-CS Recent Developments
  61. 8.11 Olympus
  62. 8.11.1 Olympus Company Information
  63. 8.11.2 Olympus Business Overview
  64. 8.11.3 Olympus Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Olympus Nitinol Medical Components Product Portfolio
  66. 8.11.5 Olympus Recent Developments
  67. 8.12 Stryker
  68. 8.12.1 Stryker Company Information
  69. 8.12.2 Stryker Business Overview
  70. 8.12.3 Stryker Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Stryker Nitinol Medical Components Product Portfolio
  72. 8.12.5 Stryker Recent Developments
  73. 8.13 Terumo Interventional Systems
  74. 8.13.1 Terumo Interventional Systems Company Information
  75. 8.13.2 Terumo Interventional Systems Business Overview
  76. 8.13.3 Terumo Interventional Systems Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Terumo Interventional Systems Nitinol Medical Components Product Portfolio
  78. 8.13.5 Terumo Interventional Systems Recent Developments
  79. 8.14 B. Braun
  80. 8.14.1 B. Braun Company Information
  81. 8.14.2 B. Braun Business Overview
  82. 8.14.3 B. Braun Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 B. Braun Nitinol Medical Components Product Portfolio
  84. 8.14.5 B. Braun Recent Developments
  85. 8.15 Boston Scientific
  86. 8.15.1 Boston Scientific Company Information
  87. 8.15.2 Boston Scientific Business Overview
  88. 8.15.3 Boston Scientific Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Boston Scientific Nitinol Medical Components Product Portfolio
  90. 8.15.5 Boston Scientific Recent Developments
  91. 8.16 Medtronic
  92. 8.16.1 Medtronic Company Information
  93. 8.16.2 Medtronic Business Overview
  94. 8.16.3 Medtronic Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Medtronic Nitinol Medical Components Product Portfolio
  96. 8.16.5 Medtronic Recent Developments
  97. 8.17 Abbott
  98. 8.17.1 Abbott Company Information
  99. 8.17.2 Abbott Business Overview
  100. 8.17.3 Abbott Nitinol Medical Components Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Abbott Nitinol Medical Components Product Portfolio
  102. 8.17.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nitinol Medical Components Value Chain Analysis
  2. 9.1.1 Nitinol Medical Components Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nitinol Medical Components Sales Mode & Process
  6. 9.2 Nitinol Medical Components Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nitinol Medical Components Distributors
  9. 9.2.3 Nitinol Medical Components Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst